Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256281 · ClinicalTrials.gov registry record · Phase 1
Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I
A Phase 1 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01256281: Clinical Trial Phase 1 study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01256281 is a Phase 1 study that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01256281, a Phase 1 study, was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The hypothesis of this study is: Femoral nerve blocks can feasibly be performed on patients with Sickle Cell Disease and painful crisis in the Emergency Department.
Primary Outcome
Pain score in legs at 2-4 hours after intervention will be the primary outcome. Data analysis not done.
Interventions
- PROCEDURE Femoral Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-08 |
| Phase | Phase 1 |
Why NCT01256281 stopped before completion
NCT01256281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Femoral Nerve Block is the first listed.
NCT01256281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01256281 about?
NCT01256281 is a clinical study titled "Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I". The hypothesis of this study is: Femoral nerve blocks can feasibly be performed on patients with Sickle Cell Disease and painful crisis in the Emergency Department.
What is the current status of trial NCT01256281?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2010-09. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01256281?
The interventions under investigation include: Femoral Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT01256281?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01256281's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia